The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project

Related News Articles

Headline
The Centers for Medicare & Medicaid Services today released a notice seeking public comment on the collection of information request regarding the State…
Headline
The Trump administration yesterday released executive orders on reducing anti-competitive regulatory barriers and repealing certain regulations deemed unlawful…
Headline
The Office of Management and Budget April 9 released a notice seeking public input on rules to potentially be rescinded, requesting detailed reasons…
Headline
In this recent episode of AHA’s Advancing Health podcast, Sara Robinson, senior associate healthcare architect at McMillan Pazdan Smith Architecture, and Jamie…
Headline
The Center for Medicare and Medicaid Innovation yesterday released its 2024 Report to Congress that includes updates on 37 models and initiatives (including…
Chairperson's File
In this Leadership Dialogue, I talk with Amy Perry, president and CEO of Banner Health, based in Phoenix. Before joining Banner Health three years ago, Amy…